期刊文献+

药物诱导与耐药基因转染两种方法建立的人食管癌顺铂耐药细胞系的比较 被引量:7

Comparison between human esophageal carcinoma drug-resistant cell lines established with two different methods
暂未订购
导出
摘要 目的比较药物诱导和耐药基因转染两种方法所建立的人食管癌顺铂耐药细胞系的不同特点。方法顺铂(cDDP)中等浓度、间歇作用法历时9个月建立食管癌耐药细胞系Ec9706/cDDP;同时采用脂质体转染法将人野生型DNA聚合酶β(polβ)的重组绿色荧光蛋白表达载体pEGFP-AC3转染入食管癌细胞Ec9706,经G418筛选得到稳定转染细胞系Ec9706-AC3。荧光显微镜观察转染效果,普通倒置显微镜观察细胞形态变化。绘制生长曲线,计算群体倍增时间。RT-PCR方法检测细胞中polβmRNA的表达水平,MTT法测细胞对顺铂的敏感性,并观察冻存复苏、撤药培养对耐药性的影响。结果两种方法所获耐药细胞与亲本细胞相比形态无明显变化,polβmRNA表达均增加。Ec9706/cDDP耐药指数为15.70±1.16,冻存复苏对耐药指数影响不大,而撤药培养可使耐药性降低,细胞群体倍增时间延长;Ec9706-AC3细胞耐药指数为1.78±0.67,不受冻存复苏、撤药培养的影响,细胞群体倍增时间不变。结论用不同方法成功建立两种人食管癌顺铂耐药细胞,不同方法获得的耐药细胞生物学特性有所不同。 Objective To compare the biological characteristics of the 2 human esophageal carcinoma drug - re- sistant cell lines established by pulse drug exposure and transfeetion of DNA polymerase beta (polβ) gene. Methods The drug - resistant cell line Ee9706/cDDP was established in culture by pulse exposing Ee9706 ceils to moderate concen- tration of cisplatin (cDDP) over a period of 9 months. The reeombined enhanced green fluorescent protein (GFP) vector pEGFP- AC3 carrying wicle type DNA poll3 gene was transfected into Ec9706 cells by iipotransfection, and the stable transfectant Ec9706 - AC3 was screened by G418. Cell growth curves were constructed for assessment of doubling time. Expression of polβ was confirmed by RT - PCR. The resistance index to cDDP was determined by the methyl thiazolyl tet- razolium assay (MTT). Results There was no significant morphologic difference between the 2 established human esophageal carcinoma drug - resistant cell lines, in which poll3 expression level was significantly increased. The resistant index of Ec9706/cDDP was 15.70 ± 1.16 and maintained after frozen resuscitation, but reduced after cultured without cDDP for 1 month. The resistant index of Ec9706 - AC3 was 1.78 ± 0.67 and not affected by frozen resuscitation or cDDP with- draw. Ahhoug doubling time of Ec9706/cDDP was prolonged, that of Ec9706 - AC3 was not affected. Conclusion Two human esophageal carcinoma drug - resistant cell lines were established by two different methods, presenting different biological characteristics.
出处 《广东医学》 CAS CSCD 北大核心 2012年第6期726-729,共4页 Guangdong Medical Journal
关键词 DNA聚合酶Β 食管癌细胞 耐药细胞 转染 DNA polymerase beta human esophageal carcinoma cell drugresistent cell transfection
  • 相关文献

参考文献14

二级参考文献24

  • 1Perez-Tomas R. Multidrug resistance: retrospect and prospects in anti cancer drug treatment [J]. Curr Med Chem, 2006,13 (16) : 1859.
  • 2Juranka PF, Zastawny RL, Ling V. P-glycoprotein: multidrug-resistance and a superfamily of membrane- associated transport proteins[J], FASEB J, 1989,3: 2583.
  • 3Huls M, Russel FG, Masereeuw R. The role of ATP binding cassette transporters in tissue defense and organ regeneration[J]. J Pharmacol Exp Ther, 2009,328 ( 1 ) : 3.
  • 4Soh Y,Goto S, Kitajima M, et al. Nuclear localisation of glutathione S-transferase pi is an evaluation factor for drug resistance in gynaecological cancers[J]. Clin Oncol, 2005,17(4) :264.
  • 5Mattern J. Drug resistance in cancer: a multifactorial problem[J]. Anticancer Res, 2003,23 (2C) : 1769.
  • 6Nishio K, Nakamura T. Conquering drug resistance in lung cancer[J]. Nippon Rinsho,2000,58(5) :1041.
  • 7Fan K, Fan D,Cheng LF, et al. Expression of multidrug resistance related markers in gastric cancer[J]. Anticancer Res,2000,20(6C) :4809.
  • 8Jeha S. New therapeutic strategies in acute lymphoblastic leukemia[J]. Semin Hematol, 2009,46 ( 1 ) : 76.
  • 9Dcormack BP,Valdivia RH, Falkow S. FACS-optimized mutants of the green fluorecent protein (GFP). Gene, 1996,173(1) :33
  • 10Ormo M,Cubitt AB, Kallio K,et al. Crystal structure of the Aequorea victoria green fluorescent pritein. Science, 1996,273(5280):1 392

共引文献23

同被引文献71

  • 1陈瑾歆,何军,张娟娟,蒲宇,王含彦.黄芪多糖对人肝癌细胞HepG2凋亡相关基因表达的影响[J].中国老年学杂志,2014,34(1):124-126. 被引量:15
  • 2温志军.晚期非小细胞肺癌患者应用顺铂化疗后MRP和LRP基因的表达[J].中国生化药物杂志,2014,34(2):108-109. 被引量:5
  • 3李敏,王志举,付庆,赵国强,董子明.人食管癌顺铂耐药细胞系的建立及耐药相关基因的筛选[J].中国卫生检验杂志,2007,17(1):18-20. 被引量:9
  • 4Noronha V,Prabhash K,Bhosale B,et al.AOS28 High pathological response rate with docetaxel plus cisplatin plus fluorouracil induction regimen in oesophageal cancer:Initial experience[J].European Journal of Cancer,2012,48(4):S13.
  • 5Nguyen NP,Krafft SP,Hung VV,et al.Feasibility of tomotherapy to reduce normal lung and cardiac toxicity for distal esophageal cancer compared to three-dimensional radiotherapy[J].Radiotherapy and Oncology,2011,101(3):438-442.
  • 6Enestvedt BK,Ginsberg GG.Advances in endoluminal therapy for esophageal cancer[J].Gastrointestinal Endoscopy Clinics of North America,2013,23(1):17-39.
  • 7THOMAS DL. Global control of hepatitis C : where challenge meets opportunity [ J ]. Nat Med, 2013,19 ( 7 ) : 850 - 858.
  • 8ELTAHLA AA, LUCIANI F, WHITE PA, et al. Inhibitors ofthe hepatitis C virus polymerase; mode of action and resistance [J]. Viruses, 2015, 7(10): 5206-5224.
  • 9WANG C, HUANG H, VALERA L, et al. Hepatitis C virus RNA elimination and development of resistance i1 replicon ceils treated with BMS-790052 [ J ]. Antimicrob Agents Chemother, 2012, 56(3) : 1350 - 1358.
  • 10LIU S, CHEN R, HAGEDORN CH, et al. Tannic acid inhibits hepatitis C virus entry into Huh7.5 Cells[ J]. PLoS One, 2015, 10(7) :1 - 18.

引证文献7

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部